SADI-S vs gastric sleeve is a comparison that increasingly arises as more patients explore advanced bariatric surgical options in the UK. Both procedures offer meaningful, sustained weight loss, but they differ significantly in complexity, mechanism, risk profile, and long-term nutritional demands. The gastric sleeve is one of the most widely performed bariatric operations in the UK, while SADI-S is a newer, more complex procedure available only at selected specialist centres under NICE Interventional Procedures Guidance. Understanding the key differences between these two operations is essential for anyone considering bariatric surgery.

What Are SADI-S and Gastric Sleeve Surgery?

The gastric sleeve removes most of the stomach to restrict food intake, while SADI-S combines a sleeve gastrectomy with a bowel bypass, making it both restrictive and malabsorptive. In the UK, SADI-S is only available at selected specialist centres under NICE Interventional Procedures Guidance special arrangements.

Have any more questions about this? Message our pharmaceutical team to get more info →

Bariatric surgery encompasses a range of procedures designed to support significant, sustained weight loss in individuals living with obesity. Two procedures that are increasingly discussed — and sometimes compared — are the Single Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy (SADI-S) and the sleeve gastrectomy (commonly known as the gastric sleeve). Both are recognised surgical interventions, though they differ considerably in complexity, mechanism, and long-term outcomes.

The gastric sleeve is one of the most commonly performed bariatric procedures in the UK. It involves the permanent removal of approximately 75–80% of the stomach, leaving a narrow, tube-shaped stomach roughly the size of a banana. It works primarily by limiting the amount of food a person can consume at one time (restriction), but also has important hormonal effects — notably a reduction in ghrelin, a hunger-stimulating hormone — which contribute meaningfully to appetite suppression and metabolic improvement.

SADI-S, by contrast, is a more complex, two-component procedure. It combines a sleeve gastrectomy with a bowel bypass element, making it both restrictive and malabsorptive. Originally developed as a simplified modification of the biliopancreatic diversion with duodenal switch (BPD/DS), SADI-S is a newer addition to the bariatric surgical toolkit.

Importantly, in the UK, SADI-S is covered by NICE Interventional Procedures Guidance (IPG), which classifies it as a procedure with limited evidence. This means it should only be performed with special arrangements: robust clinical governance, enhanced informed consent (including discussion of uncertainties in the evidence), and participation in audit or research — typically through the National Bariatric Surgery Registry (NBSR). SADI-S is available only at selected specialist centres in the UK and is not routinely commissioned across the NHS. Patients considering this procedure should ensure their centre operates within these formal frameworks.

Understanding the fundamental differences between these two procedures is an important first step for anyone exploring their surgical options.

How Each Procedure Works and What to Expect

The gastric sleeve takes 60–90 minutes laparoscopically with a one-to-two night hospital stay, while SADI-S involves additional bowel rerouting, a longer operative time, and typically two to three nights in hospital. Both require pre-operative assessment through a specialist multidisciplinary bariatric team following a tiered NHS pathway.

The gastric sleeve is performed laparoscopically (keyhole surgery) under general anaesthesia and typically takes 60–90 minutes. The surgeon uses a stapling device to remove the larger, curved portion of the stomach. The remaining sleeve-shaped stomach holds significantly less food, promoting early satiety. The reduction in ghrelin levels also contributes to reduced appetite beyond simple restriction. Most patients stay in hospital for one to two nights and can return to light activities within two to four weeks.

SADI-S also begins with a sleeve gastrectomy, but adds a second surgical step: the first part of the small intestine (the duodenum) is divided just beyond the stomach outlet, and a loop of the lower small intestine (ileum) is connected directly to it. This creates a single anastomosis (join), which is simpler than the two joins required in the traditional duodenal switch. The bypass element means that food bypasses a significant portion of the small intestine, reducing the absorption of calories and nutrients — particularly fats.

Because SADI-S involves bowel rerouting, operative time is longer and recovery slightly more involved than for a sleeve alone. Patients should expect:

• Hospital stay: typically two to three nights

• Return to normal activities: four to six weeks

• Dietary progression: from liquids to puréed, then soft, then solid foods over several weeks

Both procedures require thorough pre-operative assessment through a specialist multidisciplinary bariatric team (MDT). In the UK, this typically follows a tiered pathway, beginning with a tier 3 specialist weight management service before referral for surgical assessment. Pre-operative steps commonly include:

• A liver-reducing (low-calorie) diet for one to two weeks before surgery to reduce liver size and improve operative safety

• Optimisation of comorbidities (e.g., blood glucose, blood pressure)

• Dietetic assessment and nutritional counselling

• Psychological assessment where clinically indicated within the MDT

Patients should also be counselled before surgery on the importance of avoiding NSAIDs and smoking post-operatively (to reduce the risk of anastomotic ulceration and leak), and on contraception and pregnancy planning — it is recommended to defer pregnancy for at least 12–18 months after surgery, and long-acting reversible contraception (LARC) is preferred. Women should discuss this with their surgical team and GP before the procedure.

In line with NICE guidance on obesity (CG189 and its updates), surgical assessment should be offered through a structured pathway, and all patients should receive comprehensive pre-operative counselling.

Comparing Weight Loss Outcomes and Effectiveness

SADI-S produces approximately 28–40% total body weight loss at two to five years, compared with approximately 20–30% for the gastric sleeve, and demonstrates stronger outcomes for type 2 diabetes remission. However, SADI-S evidence remains largely observational, with limited head-to-head randomised controlled trial data.

When comparing SADI-S and gastric sleeve in terms of weight loss, the available evidence suggests that SADI-S produces greater weight loss over the medium to long term. However, it is important to interpret published figures with caution, as the evidence base for SADI-S remains largely observational, with limited head-to-head randomised controlled trial data and variability in surgical technique (particularly common channel length).

Reported outcomes include:

• SADI-S: approximately 28–40% total body weight loss (TBWL) at two to five years in published series

• Gastric sleeve: approximately 20–30% TBWL over a similar period

Long-term data on SADI-S are still accruing, and the NICE Interventional Procedures Guidance evidence overview acknowledges the limited and heterogeneous nature of current evidence. UK outcome benchmarks are available through the National Bariatric Surgery Registry (NBSR).

Beyond weight loss, SADI-S demonstrates stronger outcomes for metabolic conditions, particularly type 2 diabetes. The malabsorptive component triggers significant changes in gut hormone profiles — including GLP-1 and PYY — which enhance insulin sensitivity and glycaemic control, and may lead to remission or substantial improvement of type 2 diabetes in eligible patients. The gastric sleeve also improves metabolic markers, but generally to a lesser degree.

It is also worth noting that Roux-en-Y gastric bypass (RYGB) and one-anastomosis gastric bypass (OAGB) are well-established alternatives that may outperform the sleeve for metabolic disease and are often preferred where significant gastro-oesophageal reflux is present. Your surgical team will discuss all relevant options.

Weight loss outcomes are influenced by:

• Pre-operative BMI and metabolic health

• Adherence to dietary and lifestyle changes post-surgery

• Psychological readiness and ongoing support

• Surgical technique and centre experience

Patients should discuss realistic, individualised expectations with their surgical team before making a decision.

Risks, Complications, and NHS Eligibility Criteria

The gastric sleeve risks include staple line leak, worsening GORD, and nutritional deficiencies; SADI-S carries additional risks of fat-soluble vitamin deficiencies, protein malnutrition, diarrhoea, and anastomotic complications. NHS surgical assessment is generally recommended for adults with BMI ≥40 kg/m², or ≥35 kg/m² with a significant obesity-related condition.

All bariatric surgery carries inherent risks, and both procedures should only be undertaken after careful multidisciplinary assessment. The gastric sleeve carries risks including:

• Staple line leak (approximately 1–2% of cases)

• Gastro-oesophageal reflux disease (GORD), which may worsen post-operatively — patients with significant pre-existing reflux, oesophagitis, or Barrett's oesophagus should be aware that RYGB is generally preferred in this context

• Nutritional deficiencies, particularly iron, vitamin B12, and vitamin D

• Weight regain over time, particularly without sustained lifestyle changes

• Gallstone formation (risk increased with rapid weight loss; ursodeoxycholic acid (UDCA) prophylaxis may be prescribed according to local protocol)

SADI-S carries all of the above risks, plus additional concerns related to its malabsorptive component:

• More significant nutritional deficiencies, including fat-soluble vitamins (A, D, E, K) and protein malnutrition

• Loose stools or diarrhoea, particularly with high-fat meals

• Anastomotic leak at the duodeno-ileal join

• Marginal ulceration at the anastomosis site

• Severe protein-calorie malnutrition in a minority of cases, which may require revisional surgery

Red-flag symptoms following either procedure require urgent medical assessment. Patients should seek emergency care if they experience:

• Severe or worsening abdominal pain

• Persistent vomiting or inability to tolerate fluids (which also carries a risk of thiamine deficiency and requires urgent assessment)

• Signs of infection (fever, redness, discharge from wounds)

• Chest pain, shortness of breath, or rapid heart rate (possible signs of venous thromboembolism (VTE))

• Calf pain or swelling

• Reduced urine output or signs of dehydration

• Neurological symptoms such as confusion or visual disturbance

NHS eligibility for bariatric surgery in England is guided by NICE guidance (CG189 and updates) and NHS England commissioning policy. Surgical assessment is generally recommended for adults with:

• BMI ≥40 kg/m², or

• BMI ≥35 kg/m² with a significant obesity-related condition (such as type 2 diabetes, hypertension, or sleep apnoea)

• BMI 30–34.9 kg/m² with recent-onset type 2 diabetes may also be considered for surgical assessment in specialist centres

Access to SADI-S on the NHS is limited to selected specialist centres operating within NICE IPG special arrangements, and availability varies by region. Selection for SADI-S is individualised and based on clinical factors, not a fixed BMI threshold. Patients should speak to their GP about referral to a tier 3 specialist weight management service as the first step in the NHS pathway.

Nutritional Needs and Long-Term Follow-Up Care

SADI-S requires more extensive lifelong supplementation than the gastric sleeve, including higher doses of fat-soluble vitamins and protein, with additional blood tests for zinc, copper, selenium, and fat-soluble vitamins. BOMSS recommends annual follow-up as a minimum for both procedures, with more frequent monitoring in the first two years.

Nutritional management is a cornerstone of post-bariatric care for both procedures, but the demands are considerably greater following SADI-S due to its malabsorptive nature. Supplementation regimens should be guided by your specialist bariatric dietitian and aligned with BOMSS (British Obesity and Metabolic Surgery Society) guidelines.

After a gastric sleeve, patients typically require lifelong supplementation including:

• A complete multivitamin and mineral supplement (containing iron, zinc, and folic acid)

• Vitamin B12 — many UK centres recommend intramuscular hydroxocobalamin injections (e.g., every three months) rather than oral supplementation alone, as absorption may be unreliable; follow your centre's protocol

• Vitamin D and calcium citrate (calcium citrate is preferred over carbonate post-surgery due to better absorption without acid)

• Additional iron supplementation, particularly for menstruating women

Following SADI-S, supplementation requirements are more extensive and must be carefully monitored. Patients will generally need:

• Higher doses of fat-soluble vitamins (A, D, E, K)

• Protein supplements to prevent muscle loss — protein targets should be dietitian-guided, typically ≥60–80 g/day for sleeve patients and higher for SADI-S patients, based on individual assessment

• Thiamine (vitamin B1) supplementation if prolonged vomiting occurs, and urgent medical review in this situation

• Regular blood tests to detect deficiencies early

Recommended blood test monitoring (as a minimum guide; your centre may advise more frequently):

• At 3, 6, and 12 months post-surgery, then annually

• Tests typically include: full blood count, urea and electrolytes, liver function tests, ferritin, vitamin B12, folate, vitamin D, calcium, and parathyroid hormone (PTH)

• For SADI-S patients: additionally zinc, copper, selenium, and fat-soluble vitamins (A, E, K)

Patients should also be aware that medication formulations may need review after surgery — modified-release and enteric-coated preparations may not be absorbed reliably, and NSAIDs should be avoided where possible due to the risk of ulceration. Discuss all medications with your GP or pharmacist.

Both groups benefit from structured, long-term follow-up through a multidisciplinary bariatric team, including a bariatric surgeon, specialist dietitian, and psychological support. BOMSS recommends annual follow-up as a minimum, with more frequent monitoring in the first two years post-surgery.

Signs of nutritional deficiency to be aware of include:

• Fatigue and weakness (iron or B12 deficiency)

• Bone pain or increased fracture risk (vitamin D/calcium deficiency)

• Hair thinning (protein or zinc deficiency)

• Visual disturbances or night blindness (vitamin A deficiency — more relevant post-SADI-S)

• Tingling, numbness, or neurological symptoms (B12 or thiamine deficiency)

Any concerning symptoms should prompt prompt contact with your bariatric team or GP. Adherence to follow-up appointments and supplementation regimens is essential for long-term health and surgical success.

If you experience any suspected adverse effects from medicines, vitamin or mineral supplements, or medical devices used as part of your bariatric care, you can report these via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app.

Women planning pregnancy after bariatric surgery should defer conception for at least 12–18 months post-operatively and should be monitored closely by both their bariatric team and obstetric team, with careful attention to micronutrient status throughout pregnancy.

Choosing the Right Procedure With Your Surgical Team

The choice between SADI-S and gastric sleeve is highly individualised and should be made collaboratively with a specialist multidisciplinary bariatric team, considering clinical, psychological, and lifestyle factors. Other procedures including RYGB and OAGB should also be discussed, as they may be more appropriate in certain clinical situations.

Deciding between SADI-S and gastric sleeve is not a straightforward comparison — it is a highly individualised decision that should be made collaboratively with a specialist multidisciplinary bariatric team. There is no universally 'better' procedure; rather, the most appropriate choice depends on a range of clinical, psychological, and lifestyle factors. It is also important to consider other well-established procedures — including Roux-en-Y gastric bypass (RYGB) and one-anastomosis gastric bypass (OAGB) — which may be more suitable in certain clinical situations and which your team will discuss with you.

The gastric sleeve may be more suitable for patients who:

• Have a BMI in the range of 35–49 kg/m² without significant metabolic disease

• Prefer a less complex procedure with a shorter operative time

• Are concerned about the nutritional demands of a malabsorptive procedure

Important note on reflux: The gastric sleeve can worsen gastro-oesophageal reflux disease (GORD) and is generally not recommended for patients with significant pre-existing reflux, oesophagitis, or Barrett's oesophagus. In these cases, RYGB is typically the preferred option. This should be discussed carefully with your surgical team.

SADI-S may be considered for patients who:

• Have significant obesity-related metabolic disease (such as poorly controlled type 2 diabetes) where greater metabolic benefit is anticipated

• Have previously undergone a sleeve gastrectomy with insufficient weight loss (as a revisional procedure)

• Are willing and able to commit to intensive nutritional monitoring and supplementation

• Have been fully counselled on the greater complexity, risk profile, and the limited and still-accruing evidence base

Critically, in the UK, SADI-S is subject to NICE Interventional Procedures Guidance and must be performed with special arrangements: enhanced informed consent (including explicit discussion of the uncertainties in the evidence), robust clinical governance, and participation in audit or research — typically via the National Bariatric Surgery Registry (NBSR). Patients should confirm that their centre operates within these arrangements.

When choosing a centre, patients are encouraged to ask whether it contributes to the NBSR and to discuss audited outcomes. Transparent outcome reporting is a marker of quality and safety, and is more meaningful than volume alone.

Ultimately, the best outcomes from any bariatric procedure come from thorough preparation, realistic expectations, and a lifelong commitment to dietary and lifestyle change. Speak to your GP about a referral to a specialist tier 3 weight management service, and ensure you receive comprehensive pre-operative counselling — including discussion of all available procedures — before making your decision.

Frequently Asked Questions